Standout Papers

Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC 2018 2026 2020 2023 2.6k
  1. Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC (2018)
    Mark A. Socinski, Robert M. Jotte et al. New England Journal of Medicine

Immediate Impact

2 by Nobel laureates 8 from Science/Nature 60 standout
Sub-graph 1 of 23

Citing Papers

JAK inhibition enhances checkpoint blockade immunotherapy in patients with Hodgkin lymphoma
2024 StandoutScience
Tumour vasculature at single-cell resolution
2024 StandoutNature
2 intermediate papers

Works of Yijing Shen being referenced

Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC
2018 Standout

Author Peers

Author Last Decade Papers Cites
Yijing Shen 1186 1004 2387 1622 32 4.0k
Heribert Juergens 1037 584 1078 1501 60 3.2k
Peter Langmuir 1289 502 1811 1620 55 4.6k
Margaret Dugan 1853 1354 2441 1251 69 6.1k
Bethan Psaila 1827 1106 1498 772 59 5.4k
Tai‐Tsang Chen 978 342 2560 506 37 4.3k
Paul Frewer 1302 569 1716 2160 38 3.5k
Michael J. Stower 1698 870 2243 1143 56 4.3k
Julia Reid 1134 1210 1278 1562 63 3.9k
Steven J. Lemery 515 738 1726 812 64 3.1k
Scott Cruickshank 724 362 1197 1005 55 2.6k

All Works

Loading papers...

Rankless by CCL
2026